ALMKT:EPA
Mauna Kea Technologies SA
0,090 €
arrow_upward
+1,13%(+0,00100) 1K
19-noy, 17:35:01 (GMT+1) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALMKT tikeri uchun statistika yaratilmoqda...
Ochish
0,09 €
Yuqori
0,09 €
Past
0,09 €
Bozor kapitali
17,22 mln
Oʻrtacha hajm
472,14 ming
Hajmi
173,97 ming
P/E koeffitsiyenti
0,76
52 haftalik eng yuqori
0,23 €
52 haftalik eng past
0,07 €
Aksiya boʻyicha daromad
0,12 €
Muomaladagi aksiyalar
195,26 mln
Xodimlar soni
56
Ochish
0,09 €
Yuqori
0,09 €
Past
0,09 €
Bozor kapitali
17,22 mln
Oʻrtacha hajm
472,14 ming
Hajmi
173,97 ming
P/E koeffitsiyenti
0,76
52 haftalik eng yuqori
0,23 €
52 haftalik eng past
0,07 €
Aksiya boʻyicha daromad
0,12 €
Muomaladagi aksiyalar
195,26 mln
Xodimlar soni
56
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
The Harvard Law School Forum on Corporate Governance
·
7 soat oldin
Board Practices and Composition in the Russell 3000 and S&P 500
Barron's
·
7 soat oldin
S&P 500 Futures Rise in Premarket Trading; Credicorp, Intercorp Finl Svcs Lead
AP News
·
22 soat oldin
A fifth straight drop for the S&P 500 drags Wall Street to its longest losing streak since June
RealMoney Pro
·
20 soat oldin
Wednesday’s Charts – The S&P 500 Clings to Its Uptrend Line as Commodities Slip Further
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA haqida
CEOSacha Loiseau
Xodimlar soni56
Asos solingan2000
Bosh ofislar-
SektorHealth Care
Soha-
Veb-saytmaunakeatech.com